Early research (Phase 1)Ended earlyNCT01067066What this trial is testingA Phase I Study of TPI 287 - Temozolomide Combination in MelanomaWho this might be right forMelanoma M.D. Anderson Cancer Center 21
Testing effectiveness (Phase 2)Ended earlyNCT02748564What this trial is testingAldesleukin and Pembrolizumab in Treating Patients With Stage III-IV MelanomaWho this might be right forMetastatic MelanomaStage III Mucosal Melanoma of the Head and NeckStage IIIA Skin Melanoma+6 more Rutgers, The State University of New Jersey 10
Early research (Phase 1)Study completedNCT01183663What this trial is testingLenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)Who this might be right forAdvanced Cancers M.D. Anderson Cancer Center 180
Testing effectiveness (Phase 2)Study completedNCT04382664What this trial is testingUV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of MelanomaWho this might be right forMalignant Melanoma Ultimovacs ASA 156
Testing effectiveness (Phase 2)Study completedNCT05419388What this trial is testingMultiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic MelanomaWho this might be right forMelanoma Hoffmann-La Roche 93
Large-scale testing (Phase 3)Active Not RecruitingNCT05155254What this trial is testingIO102-IO103 in Combination With Pembrolizumab Versus Pembrolizumab Alone in Advanced Melanoma (IOB-013 / KN-D18)Who this might be right forMetastatic MelanomaUnresectable Melanoma IO Biotech 407
Testing effectiveness (Phase 2)Study completedNCT00072345What this trial is testingTemozolomide, Thalidomide, and Lomustine in Treating Patients With Unresectable Stage III or Stage IV MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin) Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT02015416What this trial is testingTrial of NY-ESO-1 With GLA-SE in Patients With Unresectable or Metastatic CancerWho this might be right forMelanomaOvarian CancerSarcoma+2 more Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 13
Early research (Phase 1)Ended earlyNCT02628535What this trial is testingSafety Study of MGD009 in B7-H3-expressing TumorsWho this might be right forMesotheliomaBladder CancerMelanoma+10 more MacroGenics 67
Early research (Phase 1)Study completedNCT04551352What this trial is testingRO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive MelanomasWho this might be right forCutaneous MelanomaUveal MelanomaMucosal Melanoma Hoffmann-La Roche 20
Early research (Phase 1)Ended earlyNCT00272415What this trial is testingIntravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With MelanomaWho this might be right forMelanoma Genentech, Inc. 39
Testing effectiveness (Phase 2)UnknownNCT05104801What this trial is testingSitravatinib With or Without Tislelizumab in Patients With Unresectable or Metastatic MelanomaWho this might be right forMelanoma Peking University Cancer Hospital & Institute 37
Testing effectiveness (Phase 2)Ended earlyNCT01604889What this trial is testingA Phase 1/2 Randomized, Blinded, Placebo Controlled Study of Ipilimumab in Combination With Epacadostat or Placebo in Subjects With Unresectable or Metastatic MelanomaWho this might be right forMelanoma Incyte Corporation 50
Testing effectiveness (Phase 2)Study completedNCT01136967What this trial is testingAn Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV MelanomaWho this might be right forUnresectable Stage IIIStage IV Melanoma Eisai Inc. 182
Testing effectiveness (Phase 2)Study completedNCT01654692What this trial is testingA Combination of Ipilimumab and Fotemustine for Treat Unresectable Locally Advanced or Metastatic MelanomaWho this might be right forMetastatic Malignant Melanoma Italian Network for Tumor Biotherapy 86
Testing effectiveness (Phase 2)Study completedNCT05578872What this trial is testingANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).Who this might be right forMelanoma (Skin)Cutaneous MelanomaAdult Disease+2 more Anaveon AG 29
Not applicableStudy completedNCT00477919What this trial is testingE-MOSAIC Electronic Tool to Monitor SymptomsWho this might be right forCancer Swiss Cancer Institute 264
Testing effectiveness (Phase 2)Ended earlyNCT04387071What this trial is testingCMP-001 and INCAGN01949 for Patients With Stage IV Pancreatic Cancer and Other Cancers Except MelanomaWho this might be right forLocally Advanced Malignant Solid NeoplasmMetastatic Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v8+1 more University of Southern California 2
Large-scale testing (Phase 3)Looking for participantsNCT07221734What this trial is testingStudy to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated Advanced [Unresectable or Metastatic] MelanomaWho this might be right forAdvanced (Unresectable or Metastatic) Melanoma mAbxience Research S.L. 632
Not applicableStudy completedNCT03448497What this trial is testingStudy of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United KingdomWho this might be right forMelanoma Bristol-Myers Squibb 333